First Mercantile Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

First Mercantile Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,140	Closed	-$269K	–	890
2020 Q4	$269K	Buy	1,140 +370	+48%	+$84.9K	0.03%	316
2020 Q3	$172K	Sell	770 -130	-14%	-$35.9K	0.02%	476
2020 Q2	$261K	Buy	+900	New	+$244K	0.03%	301
2020 Q1	–	Sell	-765	Closed	-$167K	–	907
2019 Q4	$167K	Buy	+765	New	+$155K	0.02%	524
2016 Q2	–	Sell	-1,632	Closed	-$130K	–	926
2016 Q1	$130K	Sell	1,632 -1,058	-39%	-$95.7K	0.02%	677
2015 Q4	$338K	Sell	2,690 -343	-11%	-$41.4K	0.03%	549
2015 Q3	$316K	Sell	3,033 -1,014	-25%	-$130K	0.03%	570
2015 Q2	$500K	Sell	4,047 -364	-8%	-$45.9K	0.04%	505
2015 Q1	$520K	Sell	4,411 -1,182	-21%	-$142K	0.04%	483
2014 Q4	$664K	Buy	5,593 +446	+9%	+$50.2K	0.06%	424
2014 Q3	$578K	Buy	5,147 +2,395	+87%	+$228K	0.05%	485
2014 Q2	$261K	Buy	+2,752	New	+$193K	0.02%	670
2014 Q1	–	Sell	-4,150	Closed	-$308K	–	1308
2013 Q4	$308K	Sell	4,150 -400	-9%	-$27.9K	0.02%	677
2013 Q3	$345K	Sell	4,550 -100	-2%	-$7.96K	0.03%	640
2013 Q2	$371K	Buy	+4,650	New	+$342K	0.03%	612

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

First Mercantile Trust's VRTX Position: Q1 2021 in Review

First Mercantile Trust sold out of Vertex Pharmaceuticals (VRTX) in Q1 2021, closing a stake of 1,140 shares — an estimated $269K sold.

First Mercantile Trust first reported a position in VRTX in Q2 2013 and held it in 15 quarters. The position peaked at $664K in Q4 2014. 999 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

First Mercantile Trust reported no remaining Vertex Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
First Mercantile Trust sold 1,140 Vertex Pharmaceuticals shares in Q1 2021, an estimated $269K.
First Mercantile Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 15 quarters.
First Mercantile Trust's Vertex Pharmaceuticals position peaked at $664K in Q4 2014.
999 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on First Mercantile Trust's 13F filing for Q1 2021, filed 14 May 2021.